Details of an acquisition not released when it is announced are occasionally available from a company’s SEC filings. The table below shows purchase prices disclosed in SEC filings. Additional details are also available. VWR disclosed that United Biochemicals, which it acquired in July (see IBO 7/15/13), has annual sales of around $12 million.
It is no surprise that the US budget sequestration, which took effect in March and resulted in cuts to the funding of major federal government research agencies (see IBO 3/15/13), is affecting instrument and lab product company revenues. Based on comments made on recent quarterly conference calls of publicly held instrument and laboratory product companies, […]
San Diego, CA 11/11/13—Illumina has named Francis deSouza president. He will begin his position in December. Mr. deSouze currently serves as president of Products & Services at Symantec.
Sarasota, FL 10/28/13; Houston, TX 11/6/13—PAC, a Roper Industries company, has acquired Advanced Sensors, a supplier of oil-in-water process analyzers, for £34 million ($55 million = £0.62 = $1). Advanced Sensors’ analyzers utilize ultrasonics, fluorescence, video microscopy, optical spectrometry and MS to ensure process and environmental control and offer early warning indicators of leaks and […]
Reinach, Switzerland 10/31/23; Jena, Germany 11/14/13—Analytik Jena announced that Endress+Hauser, which currently holds 47% of the company’s shares, has concluded an option agreement giving it the right to purchase an additional 28% stake through the purchase of the shares owned by the German state of Thuringia, which controls 18%, and the shares held by CEO […]
London, UK 11/12/13; London, UK 11/12/13; London, UK 11/12/13; London, UK 11/12/13—Research tools firm Oxford Instruments has announced it is in discussions to acquire publicly held Andor Technology, a provider of scientific cameras, microscope systems and analytical software, stating that the acquisition would add to its Nano-Bio business. Oxford has made an indicative offer of […]
Fourteen of the 17 companies in the IBO Laboratory Sales Index reported quarterly earnings before this issue’s publication. Including estimates for Analytik Jena (Analytical Instrumentation and Life Science) Spectris (Materials Analysis) and Tecan, third quarter revenue for the IBO Laboratory Sales Index grew 1.4%, 0.9% excluding currency, to $6,143 million. Operating profit improved 1.7% to […]
The Centers for Medicare and Medicaid Services (CMS) finalized pricing for new, analyte-specific molecular codes in late September. Compared to the former stacked code system, which did not list prices for individual tests, the average price of the new codes is 26% higher and the mean price is 25% higher. However, the median price declined […]
The FDA announced this month a proposal to eliminate artificial trans fats that are found in processed foods, such as cookies and frozen pizza. The proposal would classify artificial trans fats as a food additive, and thus requiring regulatory approval. Since 2006, the FDA has required that artificial trans fats be cited on food labels, […]
An October survey of 74 US public and private research universities by the Association of American Universities, the Association of Public and Land-grant Universities (APLU), and the Science Coalition sheds new light on the effects of the US federal budget sequestration, which began in March. Eighty-one percent of respondents reported that the sequestration had an […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
